Patrick from Denmark

Registered at the short selling broker eToro, 2 minutes ago.

» Try eToro you too
67% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

Sanofi (SNY) shares information

Sanofi – ADR

24h Change

1.82 %


Live rate: Market closed

Stock data per Tuesday 28 Mar, 2023

0.97 (+ 1.82%)
US Market is closed

Live Stock price in graph for Sanofi – ADR (SNY)

  • Latest Volume

    1,513,953 (-13.77 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    54.28 USD

  • Today low

    53.92 USD

  • 52 week high

    56.2 USD

  • 52 week low

    36.91 USD

  • YTD Change

    + 11.71 %

Quick links


Latest news about Sanofi – ADR

Below you can find the most recent news posts about Sanofi – ADR, primarily from US and UK based news sources.

Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Tuesday, 28 March 2023, 23:29:49
Shares of Sanofi were up 10.20% the week ended March 24, while Regeneron finished with a gain of 9.68%, following promising news about the company’s jointly developed medication Dupixent. Clinical trial results showed the drug reduced severe flare-ups of COPD at a far better rate than a placebo. There are currently no equivalent treatments for […]
— ValueWalk

Amgen-Sanofi patent case divides makers of antibody drugs

Tuesday, 28 March 2023, 00:51:41
Amgen Inc’s battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines. In the dispute with Sanofi and partner Regeneron, whose cholesterol-lowering monoclonal antibody drug Praluent works in a […]
— Financial Post

Supreme Court hears arguments in Amgen Repatha patent case against Sanofi

Monday, 27 March 2023, 19:45:10
The U.S. Supreme Court earlier Monday heard arguments in a patent case filed by Amgen regarding Repatha against Sanofi. Read more here.
— Seeking Alpha

Argus maintains Sanofi ADR at Buy

Monday, 27 March 2023, 16:54:37

U.S. Supreme Court hears Amgen bid to revive cholesterol drug patents

Monday, 27 March 2023, 16:35:50
WASHINGTON — The U.S. Supreme Court on Monday began hearing a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a “blatant attempt” to squeeze competitors out of the market. Amgen is appealing a lower court’s ruling that invalidated two of its patents […]
— Financial Post

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have SNY available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.